【摘 要】
：
Background: Preliminary data suggest that non-invasive methods could be useful to assess presence of oesophageal varices(OV) in liver cirrhosis.The primary objectives were to investigate non-invasive
【机 构】
：
Center for Liver cirrhosis,Beijing 302 Hospital of PLA,Beijing,China
【出 处】
：
第二届全国病毒感染与器官功能衰竭学术会议
论文部分内容阅读
Background: Preliminary data suggest that non-invasive methods could be useful to assess presence of oesophageal varices(OV) in liver cirrhosis.The primary objectives were to investigate non-invasive markers for diagnosing and grading OV in primary biliary cirrhosis.Methods: This study included a total of 106 consecutive treatment-naive patients with primary biliary cirrhosis(PBC).Results of physical examination,blood tests,and abdominal ultrasound scan (USS) were measured.Performance of non-invasive markers for OV was expressed as sensitivity,specificity,positive,and negative predictive values (PPV,NPV),accuracy,and area under the curve (AUC).
其他文献
Aim The reason why the majority of chronic hepatitis B (CHB) patients do not respond to conventional interferon α (IFNα) or pegylated interferon (Peg-IFN) treatment has not been formally demonstrated.
B- and T-lymphocyte attenuator (BTLA) negatively regulates immune responses; however,it remains unknown the expression profile and functional role of BTLA in patients with hepatocellular carcinoma (HC
RNA inference (RNAi) technology achieved good results in hepatitis B virus (HBV) treatment in vitro.But there are challenges for long-term suppression of HBV replication.In the present study,we design